KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novavax (NVAX) Total Debt: 2009-2014

Historic Total Debt for Novavax (NVAX) over the last 6 years, with Dec 2014 value amounting to $395,000.

  • Novavax's Total Debt was N/A to $45,000 in Q3 2015 from the same period last year, while for Sep 2015 it was $45,000, marking a year-over-year change of. This contributed to the annual value of $395,000 for FY2014, which is 60.66% down from last year.
  • Latest data reveals that Novavax reported Total Debt of $395,000 as of FY2014, which was down 60.66% from $1.0 million recorded in FY2013.
  • In the past 5 years, Novavax's Total Debt registered a high of $1.0 million during FY2012, and its lowest value of $300,000 during FY2011.
  • Its 3-year average for Total Debt is $806,333, with a median of $1.0 million in 2013.
  • As far as peak fluctuations go, Novavax's Total Debt surged by 240.00% in 2012, and later crashed by 60.66% in 2014.
  • Novavax's Total Debt (Yearly) stood at $320,000 in 2010, then fell by 6.25% to $300,000 in 2011, then surged by 240.00% to $1.0 million in 2012, then fell by 1.57% to $1.0 million in 2013, then plummeted by 60.66% to $395,000 in 2014.